JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Acute and 28-Day Subacute Toxicity Studies of Hexane Extracts of the Roots of Lithospermum erythrorhizon in Sprague-Dawley Rats
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Toxicological Research
  • Volume 31, Issue 4,  2015, pp.403-414
  • Publisher : The Korean Society of Toxicology
  • DOI : 10.5487/TR.2015.31.4.403
 Title & Authors
Acute and 28-Day Subacute Toxicity Studies of Hexane Extracts of the Roots of Lithospermum erythrorhizon in Sprague-Dawley Rats
Han, Chung-Tack; Kim, Myoung-Jun; Moon, Seol-Hee; Jeon, Yu-Rim; Hwang, Jae-Sik; Nam, Chunja; Park, Chong-Woo; Lee, Sun-Ho; Na, Jae-Bum; Park, Chan-Sung; Park, Hee-Won; Lee, Jung-Min; Jang, Ho-Song; Park, Sun-Hee; Han, Kyoung-Goo; Choi, Young Whan; Lee, Hye-Yeong; Kang, Jong-Koo;
  PDF(new window)
 Abstract
Lithospermum erythrorhizon has long been used as a traditional oriental medicine. In this study, the acute and 28-day subacute oral dose toxicity studies of hexane extracts of the roots of L. erythrorhizon (LEH) were performed in Sprague-Dawley rats. In the acute toxicity study, LEH was administered once orally to 5 male and 5 female rats at dose levels of 500, 1,000, and 2,000 mg/kg. Mortality, clinical signs, and body weight changes were monitored for 14 days. Salivation, soft stool, soiled perineal region, compound-colored stool, chromaturia and a decrease in body weight were observed in the extract-treated groups, and no deaths occurred during the study. Therefore, the approximate lethal dose (ALD) of LEH in male and female rats was higher than 2,000 mg/kg. In the subacute toxicity study, LEH was administered orally to male and female rats for 28 days at dose levels of 25, 100, and 400 mg/kg/day. There was no LEH-related toxic effect in the body weight, food consumption, ophthalmology, hematology, clinical chemistry and organ weights. Compound-colored (black) stool, chromaturia and increased protein, ketone bodies, bilirubin and occult blood in urine were observed in the male and female rats treated with the test substance. In addition, the necropsy revealed dark red discoloration of the kidneys, and the histopathological examination showed presence of red brown pigment or increased hyaline droplets in the renal tubules of the renal cortex. However, there were no test substance-related toxic effects in the hematology and clinical chemistry, and no morphological changes were observed in the histopathological examination of the kidneys. Therefore, it was determined that there was no significant toxicity because the changes observed were caused by the intrinsic color of the test substance. These results suggest that the no-observed-adverse-effect Level (NOAEL) of LEH is greater than 400 mg/kg/day in both sexes.
 Keywords
Lithospermum erythrorhizon;Shikonin derivatives;Acute oral toxicity;28-Day subacute oral toxicity;
 Language
English
 Cited by
 References
1.
World Health Organization. (2002) WHO traditional medicine strategy. WHO, Geneva, pp. 2002-2005.

2.
Jakkula, M., Boucher, T.A., Beyendorff, U., Conn, S.M., Johnson, J.E., Nolan, C.J., Peine, C.J. and Albrecht, J.H. (2004) A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C. Arch. Intern. Med., 164, 1341-1346. crossref(new window)

3.
Haller, C.A. and Benowitz, N.L. (2000) Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N. Engl. J. Med., 343, 1833-1838. crossref(new window)

4.
Palmer, M.E., Haller, C., McKinney, P.E., Klein-Schwartz, W., Tschirgi, A., Smolinske, S.C., Woolf, A., Sprague, B.M., Ko, R., Everson, G., Nelson, L.S., Dodd-Butera, T., Bartlett, W.D. and Landzberg, B.R. (2003) Adverse events associated with dietary supplements: an observational study. Lancet, 361, 101-106. crossref(new window)

5.
Pittler, M.H. and Ernst, E. (2003) Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment. Pharmacol. Ther., 18, 451-471. crossref(new window)

6.
Papageorgiou, V.P., Assimopoulou, A.N., Couladouros, E.A., Hepworth, D. and Nicolaou, K.C. (1999) The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angew. Chem. Int. Ed., 38, 270-301. crossref(new window)

7.
Papathanasiou, K., Papageorgiou, C., Panidis, D. and Mantalenakis, S. (1999) Our experience in laparoscopic diagnosis and management in women with chronic pelvic pain. Clin. Exp. Obstet. Gynecol., 26, 190-192.

8.
Chen, X., Yang, L., Oppenheim, J.J. and Howard, M.Z. (2002) Cellular pharmacology studies of shikonin derivatives. Phytother. Res., 16, 199-209. crossref(new window)

9.
Choi, S.B., Bae, G.S., Jo, I.J., Park, K.C., Seo, S.H., Kim, D.G., Shin, J.Y., Gwak, T.S., Lee, J.H., Lee, G.S, Park, S.J. and Song, H.J. (2013) The anti-inflammatory effect of Lithospermum Erythrorhizon on lipopolysaccharide - induced inflammatory response in RAW 264.7 cells. Korea J. Herbology, 28, 67-73. crossref(new window)

10.
Chung, H.S., Kang, M., Cho, C., Park, S., Kim, H., Yoon, Y.S., Kang, J., Shin, M.K., Hong, M.C. and Bae, H. (2005) Inhibition of lipopolysaccharide and interferon-gammainduced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by Lithospermi radix in mouse peritoneal macrophages. J. Ethnopharmacol., 102, 412-417. crossref(new window)

11.
Han, K.Y., Kwon, T.H., Lee, T.H., Lee, S.J., Kim, S.H. and Kim, J. (2008) Suppressive effects of Lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of AP-1 and NFkappaB via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep., 41, 328-333. crossref(new window)

12.
Jin, R., Wan, L.L., Mitsuishi, T., Kodama, K. and Kurashige, S. (1994) Immunomodulative effects of Chinese herbs in mice treated with anti-tumor agent cyclophosphamide. Yakugaku Zasshi, 114, 533-538.

13.
Gong, K. and Li, W. (2011) Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Free Radical Biol. Med., 51, 2259-2271. crossref(new window)

14.
Chen, X., Yang, L., Zhang, N., Turpin, J.A., Buckheit, R.W., Osterling, C., Oppenheim, J.J. and Howard, O.M. (2003) Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob. Agents Chemother., 47, 2810-2816. crossref(new window)

15.
Pietrosiuk, A., Skopinska-Rozewska, E., Furmanowa, M., Wiedenfeld, H., Sommer, E., Sokolnicka, I., Rogala, E., Radomska-Lesniewska, D., Bany, J. and Malinowski, M. (2004) Immunomodulatory effect of shikonin derivatives isolated from Lithospermum canescens on cellular and humoral immunity in Balb/c mice. Pharmazie, 59, 640-642.

16.
Kim, S.M., Cho, U.S. and Sung, S.K. (1999) Effect of ethanol extract in Pinus densiflora, Lithospermun erythrorhizon on the lipid oxidation oil emulsion. J. Korean Soc. Food Sci. Nutr., 28, 984-989.

17.
Chung, H.S., Kang, M., Cho, C., Park, S., Kim, H., Yoon, Y.S., Kang, J., Shin, M.K., Hong, M.C. and Bae, H. (2005) Inhibition of lipopolysaccharide and interferon-gammainduced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by Lithospermi radix in mouse peritoneal macrophages. J. Ethnopharmacol., 102, 412-417. crossref(new window)

18.
Ju, J.H., Cho, H.H. and Lee, Y.S. (2010) Progress on phytochemical and atopic dermatitis-related study of the root of Lithospermum erythrorhizon. Korean J. Pharmacogn., 41, 73-88.

19.
Kim, S.H., Lee, J.Y. and Kim, D.K. (2005) Effects of mori folium, arctii fructus, Lithospermum Erythrorhizon on the anti-allergic response. J. Kyung Hee Univ. Med. Cent., 21, 71-79.

20.
Jeong, Y.S., Jung, H.K. and Hong, J.H. (2013) Protective effect of mulberry and Lithospermum erythrorhizon extracts on anti-aging against photodamage. J. Korean Soc. Food Sci. Nutr., 42, 1744-1752. crossref(new window)

21.
Ishida, T. and Sakaguchi, I. (2007) Protection of human keratinocytes from UVB-induced inflammation using root extract of Lithospermum erythrorhizon. Biol. Pharm. Bull., 30, 928-934. crossref(new window)

22.
Lee, H.H. and Song, S.Y. (2010) A study of effectiveness of Lithospermum erythrorhizon extracts on the skin by UVBirradiation C57BL/6 mouse. Korean J. Microsc., 40, 139-145.

23.
Park, Y.H. and Nam, Y.J. (2003) The antibacterial activity and deodorization of fabrics dyed with Lithospermi Radix extract. J. Korean Soc. Clothing Text., 27, 60-66.

24.
Papageorgioua, V.P., Assimopoulou, A.N., Samanidou, V.F. and Papadoyannis, I.N. (2006) Recent advances in chemistry, biology and biotechnology of alkannins and shikonins. Curr. Org. Chem., 10, 2123-2142. crossref(new window)

25.
Bae, J.H. (2004) Antimicrobial effect of Lithospermum erythrorhizon extracts on the food-borne pathogens. Korean J. Food Sci. Technol., 36, 823-827.

26.
Rajasekar, S., Park, D.J., Park, C., Park, S., Park, Y.H., Kim, S.T., Choi, Y.H. and Choi, Y.W. (2012) In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma. J. Ethnopharmacol., 144, 335-345. crossref(new window)

27.
Lee, J.M., Lee, M.A., Do, H.N., Bae, R.J.N., Lee, M.J., Kim, M.J., Jang, H.S., Park, S.H., Lee, H.Y., Kang, J.S. and Kang, J.K. (2012) Historical control data from 4-week repeated toxicity studies in Crj:CD(SD) rats. J. Exp. Biomed. Sci., 18, 268-275.

28.
Hall, A.P., Elcombe, C.R., Foster, J.R., Harada, T., Kaufmann, W., Knippel, A., Kuttler, K., Malarkey, D.E., Maronpot, R.R., Nishikawa, A., Nolte, T., Schulte, A., Strauss, V. and York, M.J. (2012) Liver hypertrophy a review of adaptive (adverse and non-adverse) changes-conclusions from the 3rd international ESTP Expert Workshop. Toxicol. Pathol., 40, 971-994. crossref(new window)

29.
Olson, M.J., Johnson, J.T. and Reidy, C.A. (1990) A comparison of male rat and human urinary proteins: implications for human resistance to hyaline droplet nephropathy. Toxicol. Appl. Pharmacol., 102, 524-536. crossref(new window)

30.
Greaves, P. (2000) Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation (2nd edition). Elsevier, Amsterdam, pp. 564-565.